Skip to main content

Bristol Myers Squibb income statement

  • BMY · NYSE
  • Pharmaceuticals
  • S&P 500
$63.43+1.78%Close 13 Nov 2026 · Market value $128.9B

Bristol Myers Squibb reported revenue of $48.2 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), down 0.2% from fiscal 2024. Net income was $7.05 billion and diluted earnings per share $3.46.

From Bristol Myers Squibb's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Bristol Myers Squibb income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$15.62B$17.71B$18.81B$19.48B$21.24B$17.62B$16.39B$15.88B$16.56B$19.43B$20.78B$22.56B$26.14B$42.52B$46.38B$46.16B$45.01B$48.30B$48.19B$50.03B
Revenue growth—+13.4%+6.2%+3.6%+9.0%−17.1%−7.0%−3.1%+4.3%+17.3%+6.9%+8.6%+15.9%+62.6%+9.1%−0.5%−2.5%+7.3%−0.2%—
Cost of revenue$4.92B$5.32B$5.14B$5.28B$5.60B$4.61B$4.62B$3.93B$3.91B$4.95B$6.01B$6.47B$8.08B$11.77B$9.94B$10.14B$10.69B$13.97B$13.94B$15.39B
Gross profit$10.70B$12.40B$13.67B$14.21B$15.65B$13.01B$11.77B$11.95B$12.65B$14.48B$14.68B$16.09B$18.07B$30.75B$36.45B$36.02B$34.31B$34.33B$34.26B$34.64B
Gross margin68.5%70.0%72.7%72.9%73.6%73.8%71.8%75.2%76.4%74.5%70.7%71.3%69.1%72.3%78.6%78.0%76.2%71.1%71.1%69.2%
Research and development$3.16B$3.51B$3.65B$3.57B$3.84B$3.90B$3.73B$4.53B$5.92B$5.01B$6.47B$6.33B$6.15B$10.05B$10.20B$9.51B$9.30B$11.16B$9.95B$10.56B
Selling, general and administrative$3.94B$4.14B$3.95B$3.69B$4.20B$4.22B$4.94B$4.82B$4.84B$4.98B$4.75B$4.55B$4.87B$7.66B$7.69B$7.81B$7.77B$8.41B$7.27B$7.32B
Operating expenses——————$8.68B$9.36B———$10.98B————————
Operating income—$5.09B$5.79B$6.22B$7.13B$2.52B$3.09B$2.58B$2.26B$6.08B$5.33B$5.11B$5.91B−$9.19B$7.38B$8.29B$7.28B−$7.49B$10.00B$11.56B
Operating margin—28.7%30.8%31.9%33.5%14.3%18.9%16.3%13.7%31.3%25.6%22.7%22.6%−21.6%15.9%18.0%16.2%−15.5%20.8%23.1%
Interest expense—$310.0M$184.0M$145.0M$145.0M$182.0M$199.0M$203.0M$184.0M$167.0M$196.0M$183.0M$656.0M$1.42B$1.33B$1.23B$1.17B$1.95B$1.89B$1.65B
Income before tax$2.52B$4.78B$5.60B$6.07B$6.98B$2.34B$2.89B$2.38B$2.08B$5.92B$5.13B$5.97B$4.97B−$6.87B$8.10B$7.71B$8.44B−$8.38B$9.33B$11.33B
Income tax expense$471.0M$1.09B$1.18B$1.56B$1.72B−$161.0M$311.0M$352.0M$446.0M$1.41B$4.16B$1.02B$1.51B$2.12B$1.08B$1.37B$400.0M$554.0M$2.27B$2.09B
Effective tax rate18.7%22.8%21.1%25.7%24.7%−6.9%10.8%14.8%21.5%23.8%81.0%17.1%30.5%−30.9%13.4%17.7%4.7%−6.6%24.4%18.4%
Net income$2.17B$5.25B$10.61B$3.10B$3.71B$1.96B$2.56B$2.00B$1.56B$4.46B$1.01B$4.92B$3.44B−$9.02B$6.99B$6.33B$8.03B−$8.95B$7.05B$9.24B
Net margin13.9%29.6%56.4%15.9%17.5%11.1%15.6%12.6%9.5%22.9%4.8%21.8%13.2%−21.2%15.1%13.7%17.8%−18.5%14.6%18.5%
Net income to common shareholders——$10.55B$3.09B—$1.96B$2.56B$2.00B————————————
EPS · diluted$1.09$2.62$5.34$1.79$2.16$1.16$1.54$1.20$0.93$2.65$0.61$3.01$2.01−$3.99$3.12$2.95$3.86−$4.41$3.46$4.52
Diluted weighted average shares2.0B2.0B2.0B1.7B1.7B1.7B1.7B1.7B1.7B1.7B1.7B1.6B1.7B2.3B2.2B2.1B2.1B2.0B2.0B2.0B
Basic weighted average shares——2.0B1.7B1.7B1.7B1.6B1.7B1.7B1.7B1.6B1.6B1.7B2.3B2.2B2.1B2.1B2.0B2.0B2.0B
EBITDA—$5.65B$6.25B$6.82B$7.75B$3.20B$4.71B$3.05B$2.64B$6.46B$6.12B$5.75B$7.66B$1.20B$18.06B$18.57B$17.04B$2.11B$14.01B$14.38B
EBITDA margin—31.9%33.3%35.0%36.5%18.2%28.8%19.2%15.9%33.3%29.4%25.5%29.3%2.8%38.9%40.2%37.9%4.4%29.1%28.7%
Depreciation & amortization$542.0M$562.0M$469.0M$607.0M$628.0M$681.0M$1.62B$467.0M$376.0M$382.0M$789.0M$637.0M$1.75B$10.38B$10.69B$10.28B$9.76B$9.60B$4.01B$2.82B
Stock-based compensation$133.0M$181.0M$183.0M$193.0M$161.0M$154.0M$191.0M$213.0M$235.0M$205.0M$199.0M$221.0M$441.0M$779.0M$583.0M$457.0M$518.0M$507.0M$553.0M$552.0M
Dividends per share$1.15$1.24$1.25$1.29$1.33$1.37$1.41$1.45$1.49$1.53$1.57$1.61$1.68$1.84$2.01$2.19$2.31$2.42$2.49$2.52

Quarterly

Bristol Myers Squibb income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$11.48B$11.87B$12.20B$11.89B$12.34B$11.20B$12.27B$12.22B$12.50B$11.49B$12.97B$13.07B
Cost of revenue$2.75B$2.93B$3.27B$2.96B$4.81B$3.03B$3.37B$3.44B$4.10B$3.42B$3.73B$4.15B
Gross profit$8.73B$8.93B$8.93B$8.94B$7.53B$8.17B$8.90B$8.79B$8.40B$8.07B$9.25B$8.92B
Gross margin76.1%75.3%73.2%75.1%61.0%72.9%72.5%71.9%67.2%70.2%71.3%68.3%
Research and development$2.48B$2.69B$2.90B$2.37B$3.19B$2.26B$2.58B$2.53B$2.59B$2.65B$2.96B$2.37B
Selling, general and administrative$2.07B$2.37B$1.93B$1.98B$2.14B$1.58B$1.71B$1.79B$2.18B$1.62B$1.83B$1.70B
Operating income$1.30B−$11.44B$1.56B$1.91B$480.0M$3.31B$2.27B$3.01B$1.42B$3.27B$4.03B$2.84B
Operating margin11.4%−96.4%12.8%16.1%3.9%29.6%18.5%24.6%11.4%28.5%31.0%21.8%
Interest expense$316.0M$425.0M$521.0M$505.0M$496.0M$494.0M$485.0M$480.0M$432.0M$411.0M$407.0M$403.0M
Income before tax$1.67B−$11.52B$1.29B$1.68B$175.0M$2.97B$1.77B$3.11B$1.47B$3.24B$4.09B$2.54B
Income tax expense−$88.00M$392.0M−$398.0M$461.0M$99.00M$509.0M$460.0M$919.0M$384.0M$561.0M$770.0M$374.0M
Effective tax rate−5.3%−3.4%−30.9%27.5%56.6%17.1%25.9%29.5%26.1%17.3%18.8%14.7%
Net income$1.76B−$11.91B$1.68B$1.21B$72.00M$2.46B$1.31B$2.20B$1.09B$2.68B$3.32B$2.16B
Net margin15.4%−100%13.8%10.2%0.6%21.9%10.7%18.0%8.7%23.3%25.6%16.5%
EPS · diluted$0.87−$5.89$0.83$0.60$0.04$1.20$0.64$1.08$0.53$1.31$1.62$1.05
Diluted weighted average shares2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.1B
Basic weighted average shares2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B
EBITDA$3.77B−$8.90B$4.12B$4.48B$2.36B$4.32B$3.30B$4.03B$2.40B$3.87B$4.63B$3.48B
EBITDA margin32.8%−75.0%33.8%37.6%19.1%38.6%26.9%33.0%19.2%33.6%35.7%26.7%
Depreciation & amortization$2.46B$2.53B$2.56B$2.57B$1.88B$1.01B$1.03B$1.03B$977.0M$594.0M$610.0M$642.0M
Stock-based compensation$127.0M$133.0M$125.0M$129.0M$120.0M$144.0M$137.0M$139.0M$133.0M$146.0M$135.0M$138.0M
Dividends per share$0.60$0.60$0.60$0.60$0.62$0.62$0.62$0.62$0.63$0.63$0.63$0.63

The main figures as JSON and plain text. See data and methodology.

BMY in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.